These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9431003)

  • 1. [Association of IgA anti-GM1 antibody with antecedent diarrhea in patients with Guillain-Barré syndrome].
    Koga M; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1997 Sep; 37(9):848-50. PubMed ID: 9431003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-GM1 IgA antibodies in Guillain-Barré syndrome.
    Ilyas AA; Mithen FA; Chen ZW; Cook SD
    J Neuroimmunol; 1992 Jan; 36(1):69-76. PubMed ID: 1735770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM 1 antibodies in Guillain-Barré syndrome: isotypes, course and clinical outcome.
    Seiser A; Pötzl G; Safoschnik G; Pichler S; Bernheimer H; Schwerer B
    Wien Klin Wochenschr; 1994; 106(6):159-63. PubMed ID: 8197746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
    Rees JH; Gregson NA; Hughes RA
    Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
    Koga M; Yuki N; Takahashi M; Saito K; Hirata K
    J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guillain-Barre syndrome and antibodies to ganglioside GM1. Case report].
    Trisković I; Dimitrijević Lj; Rakocević-Stojanović V; Trikić R; Apostolski S
    Srp Arh Celok Lek; 1996; 124(7-8):210-3. PubMed ID: 9102850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
    Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
    Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
    Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
    Koga M; Yuki N; Hirata K
    J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
    van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
    J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal degeneration in the Guillain-Barré syndrome and anti-GM1 ganglioside antibodies.
    Yuki N; Sato S; Inuzuka T; Miyatake T; Yoshino H
    Muscle Nerve; 1992 Jan; 15(1):116. PubMed ID: 1732757
    [No Abstract]   [Full Text] [Related]  

  • 20. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
    Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
    Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.